Ligand Pharmaceuticals

NASDAQ: LGND · Real-Time Price · USD
113.44
-0.71 (-0.62%)
At close: Jun 30, 2025, 12:36 PM

Ligand Pharmaceuticals Revenue

Ligand Pharmaceuticals reported an annual revenue of $167.13M, reflecting a 27.28% growth. For the quarter ending March 31, 2025, Ligand Pharmaceuticals generated $45.33M in revenue.
Revenue (ttm)
$167.13M
Revenue Growth
27.28%
Price / Sales Ratio
11.73
Revenue / Employee
$2.46M
Employees
68
Market Cap
2.19B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.